ASC Coding, Billing & Collections

Medicare recently released data concerning the costliest prescription medicines in 2015, according to The Wall Street Journal.

In almost a week, the trial over Indianapolis-based Anthem's proposed purchase of Cigna, based in Bloomfield, Conn., will go to trial, according to Hartford Courant.

Anthem recently filed plans to switch 500,000 Californians to health plans that do not offer coverage for out-of-network care, leading Santa Monica, Calif.-based Consumer Watchdog to file papers asking a judge to step in, according to Los Angeles Times.

Miami-based CareCloud completed a $31.5 million series C financing round.

On the heels of the 2016 election, the ACA had the highest number of signups during the open enrollment period this year, according to The Hill.

While value-based care continues to gain traction in the U.S., several insurers in New Jersey are already seeing promising results, NJSpotlight reports.

Los Angeles Times investigated whether California could keep Covered California, its ACA exchange, up and running if President-elect Donald Trump keeps good on his promise to repeal the act.

Even though Canonsburg, Pa.-based Mylan Pharmaceuticals agreed in October to pay $465 million to settle a U.S. Department of Justice investigation into EpiPen, the company is still working on finalizing the settlement, Fortune reports.

Nashville, Tenn.-based Surgery Partners had a strong third quarter headlined by an 18 percent increase in revenue to $282.7 million from 2015.

With the release of the Medicare Access and CHIP Reauthorization Act final rule last month, the move toward pay-for-performance has crossed a Rubicon. No longer a theoretical concept or something to worry about in some distant future, it is something…